Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment and Control of Modifiable Risk Factors for Primary and Secondary Prevention

NCT06503341 is registered in ClinicalTrials.gov with National Institute of Cardiovascular Diseases, Pakistan as lead sponsor.

NCT NCT06503341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06503341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment and Control of Modifiable Risk Factors for Primary and Secondary Prevention
Lead sponsor
National Institute of Cardiovascular Diseases, Pakistan
Phase
Observational
Overall status
Recruiting
Start date
June 17, 2021
Completion date
June 1, 2041
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular morbidity, cardiovascular risk assesment, primary prevention cvd